CBX3 and ovarian serous adenocarcinoma: In addition, serous ovarian cancer patients with elevated expression of CBX3 mRNA presented a significantly worse OS (HR = 1.25 (1.04 - 1.50), P = 0.0179) but a better PFS (HR = 0.84 (0.72 - 0.98), P = 0.0268).